A clinical lens on
peptide medicine.
Understand the evidence, the limitations, and whether a specific medicine has a role in your care.
What your evaluation may include.
Start with the indication
Peptides are a broad class of molecules. Some peptide medicines are FDA-approved for specific conditions; others remain investigational or have limited human evidence.
Evaluate the evidence
We discuss what is known about a specific option, what remains uncertain, and how approval status and product quality affect the decision.
Keep safety central
Consultation is not a promise of access to any particular peptide. Appropriateness, regulation, sourcing, and monitoring must be assessed before treatment.
From conversation to a clear plan.
Understand
Discuss your priorities and review your history, medications, and relevant records.
Evaluate
Determine whether tests, an examination, or a referral will be useful.
Decide together
Review suitable options, benefits, risks, alternatives, and follow-up.
Know what you’re considering.
Approval status, potential benefits, risks, and evidence limitations belong in the treatment conversation.
FDA: Safety considerations for certain compounded substancesBefore you begin.
Are all peptides FDA-approved?
No. Approval applies to a specific drug product and indication, not to the entire peptide category. Compounded products are not FDA-approved.
Do you sell research peptides?
This is a clinical evaluation service, not a research-chemical marketplace. Products labeled “research use only” should not be treated as medicines approved for patient use.
Can peptides reverse aging or guarantee recovery?
No such guarantee is offered. We discuss specific indications and clinical evidence rather than broad claims about anti-aging, healing, or performance.
Start with a conversation.
Free consultation. All other services and packages starting at $198. Tell us what you’re looking for. We’ll confirm your location, appointment availability, and the next step.
Book a free consultation